Literature DB >> 6759140

Duration of complete response to chemotherapy in advanced breast cancer.

J Fischer, C J Rose, R D Rubens.   

Abstract

Twenty-seven patients with advanced breast cancer with complete response (CR) to chemotherapy have been analysed and observed for up to 8 years. Median time to attainment of CR was 8.1 months (range, 1-19.5) and median duration of CR was 27.5 months (1-97 + months). Most (16) recurrences occurred in the first 2 years. In 12 patients (63%) relapse was at sites initially involved. No clear relationship between the duration of CR and a variety of prognostic factors or the dose of cytotoxic drugs given was found, although there was a tendency to longer duration of CR when fewer sites were involved. The presence of visceral disease did not preclude a prolonged CR. It seems that despite some patients surviving many years, relapse is inevitable and cure of the disease is unlikely with presently available chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759140     DOI: 10.1016/0277-5379(82)90073-6

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  2 in total

Review 1.  Key issues in the treatment of advanced breast cancer. Expectations and outcomes.

Authors:  R D Rubens
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

2.  Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer.

Authors:  E G de Vries; S Rodenhuis; H C Schouten; P S Hupperets; W V Dolsma; J V Lebesque; G H Blijham; M Bontenbal; N H Mulder
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.